Evidence map›Paper›PMID 34129651›Full record

ArticlePloS one2021

Bacillus velezensis strain MBY2, a potential agent for the management of crown gall disease.

Haifa Ben Gharsa, Meriam Bouri, Amira Mougou Hamdane, Christina Schuster, Andreas Leclerque, Ali Rhouma

Abstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Biocontrol of Crown Gall Disease of Cherry Trees byPlants (Basel, Switzerland) · 2025
    Article
  6. Microorganisms · 2024
    Article
  7. Article
  8. Food science and biotechnology · 2023
    Article
  9. Article
  10. Article
  11. NativeFrontiers in microbiology · 2023
    Article
  12. Article
  13. First Report of Crown Gall of Kiwifruit (International journal of molecular sciences · 2021
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Haifa Ben GharsaLaboratory of Protection and Improvement of Genetic Resources of Olive, Olive Tree Institute, Tunis, Tunisia.ORCID 0000-0001-9732-9184
Meriam BouriLaboratory of Protection and Improvement of Genetic Resources of Olive, Olive Tree Institute, Tunis, Tunisia.
Amira Mougou HamdaneNational Institute of Agronomy of Tunis, University of Carthage, Tunis, Tunisia.
Christina SchusterInstitute for Microbiology and Biochemistry, Hochschule Geisenheim University, Geisenheim, Germany.
Andreas LeclerqueInstitute for Microbiology and Biochemistry, Hochschule Geisenheim University, Geisenheim, Germany.ORCID 0000-0003-0688-4137
Ali RhoumaLaboratory of Protection and Improvement of Genetic Resources of Olive, Olive Tree Institute, Tunis, Tunisia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The reduction of the use chemical pesticides in agriculture is gaining importance as an objective of decision-makers in both politics and economics. Consequently, the development of technically efficient and economically affordable alternatives as, e.g., biological control agents or practices is highly solicited. Crown gall disease of dicotyledonous plants is caused by ubiquitous soil borne pathogenic bacteria of the Agrobacterium tumefaciens species complex, that comprises the species Agrobacterium fabrum and represents a globally relevant plant protection problem. Within the framework of a screening program for bacterial Agrobacterium antagonists a total of 14 strains were isolated from Tunisian soil samples and assayed for antagonistic activity against pathogenic agrobacteria. One particularly promising isolate, termed strain MBY2, was studied more in depth. Using a Multilocus Sequence Analysis (MLSA) approach, the isolate was assigned to the taxonomic species Bacillus velezensis. Strain MBY2 was shown to display antagonistic effects against the pathogenic A. fabrum strain C58 in vitro and to significantly decrease pathogen populations under sterile and non-sterile soil conditions as well as in the rhizosphere of maize and, to a lower extent, tomato plants. Moreover, the ability of B. velezensis MBY2 to reduce C58-induced gall development has been demonstrated in vivo on stems of tomato and almond plants. The present study describes B. velezensis MBY2 as a newly discovered strain holding potential as a biological agent for crown gall disease management.

Indexed as

AgrobacteriumAntibiosisBacillusBiological Control AgentsContainment of BiohazardsMicrobial ViabilityPhylogenyPlant TumorsRhizosphereSoil MicrobiologySolanum lycopersicumZea maysBiological Control Agents

Identifiers

PMID34129651
PMCPMC8205166

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.